Clinical Trials Directory

Trials / Completed

CompletedNCT03832790

Sleep, Glycemic Control, and Insulin Resistance in Adolescents With Type 1 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
23 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
14 Years – 19 Years
Healthy volunteers

Summary

Despite advancements in care, most adolescents with T1D have higher BMI and significantly higher HbA1c than recommended and are markedly IR, placing them at increased risk for CVD1,2. Thus, alternative approaches to improve and maintain glycemic control, IR, and BMI for adolescents with T1D are urgently needed. This proposal moves beyond the current insulin and carbohydrate counting-focused lifestyle change paradigm to focus on sleep and circadian misalignment, which will allow for identification of new mechanisms that can be directly translated into future intervention and prevention trials. The goal of the current study is to utilize multiple objective measures of sleep duration, timing (actigraphy), and circadian rhythm (melatonin) in adolescents with type 1 diabetes (T1D; N = 40) and examine relationships with glycemic control, IR, vascular health, and BMI. Further, qualitative methodology will be used to identify barriers and facilitators to healthy sleep in adolescents with T1D.

Conditions

Interventions

TypeNameDescription
OTHERobservationobservation

Timeline

Start date
2019-12-04
Primary completion
2023-05-31
Completion
2023-06-30
First posted
2019-02-06
Last updated
2024-10-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03832790. Inclusion in this directory is not an endorsement.